» Articles » PMID: 33329401

C-Peptide: A Mediator of the Association Between Serum Uric Acid to Creatinine Ratio and Non-Alcoholic Fatty Liver Disease in a Chinese Population With Normal Serum Uric Acid Levels

Overview
Specialty Endocrinology
Date 2020 Dec 17
PMID 33329401
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The data on the relationship between normal-ranged serum uric acid (SUA), β-cell function, and non-alcoholic fatty liver disease (NAFLD) are complicated and insufficient. Moreover, uric acid is excreted by kidney, and SUA levels may be affected by renal function. Thus, we introduced a renal function-normalized index [serum uric acid to creatinine ratio (SUA/Cr)] into the study and explored the association between SUA/Cr, C-peptide and NAFLD in a Chinese population with normal SUA levels by a cross-sectional analysis.

Materials And Methods: A total of 282 individuals with normal SUA levels and different glucose tolerance status from a diabetes project were included in the study (mean age = 53.7± 10.5 years; women = 64.50%). NAFLD was diagnosed by abdominal ultrasonography (NAFLD, n=86; without NAFLD, n=196). Trapezoid formula was used to calculate area under the curve of C-peptide (AUC) from 4 points (including 0, 30,60, and 120min) during 2-h oral glucose tolerance test. Spearman correlation analysis was used to explore the correlation between SUA/Cr, AUC and NAFLD risk factors. Multiple logistic regression analysis was used to explore the association between SUA/Cr or AUC and NAFLD. Mediation analysis was used to explore whether AUC mediated the association between SUA/Cr and NAFLD.

Results: Individuals with NAFLD had significantly higher SUA/Cr and AUC than those without NAFLD(P<0.05). Spearman correlation analysis showed that both SUA/Cr and AUC were significantly associated with many NAFLD risk factors, and SUA/Cr was positively correlated with AUC (P<0.05). Multiple logistic regression analysis indicated that SUA/Cr and AUC were positively associated with NAFLD incidence (P<0.05). Medication analysis indicated that SUA/Cr had a significant direct effect on NAFLD (β =0.5854, 95% CI: 0.3232-0.8966), and AUC partly mediated the indirect effect of SUA/Cr on NAFLD incidence (β =0.1311, 95% CI: 0.0168-0.4663).

Conclusions: SUA/Cr was positively associated with NAFLD incidence, and AUC partly mediated the association in a Chinese population with normal SUA levels. Thus, we should pay more attention to high-normal SUA and C-peptide levels due to their predictive power in NAFLD incidence.

Citing Articles

Serum uric acid/creatinine ratio and 1-year stroke recurrence in patient with acute ischemic stroke and abnormal renal function: results from the Xi'an stroke registry study of China.

Liu Z, Zhang D, Zeng L, Guo W, Lu Q, Lei Z Front Neurol. 2025; 16:1496791.

PMID: 39968452 PMC: 11832382. DOI: 10.3389/fneur.2025.1496791.


Association of serum uric acid to serum creatinine ratio with 1-year stroke outcomes in patients with acute ischemic stroke: A multicenter observational cohort study.

Zhang D, Liu Z, Guo W, Lu Q, Lei Z, Liu P Eur J Neurol. 2024; 31(12):e16431.

PMID: 39104135 PMC: 11555002. DOI: 10.1111/ene.16431.


Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis.

Cao L, An Y, Liu H, Jiang J, Liu W, Zhou Y BMC Med. 2024; 22(1):101.

PMID: 38448943 PMC: 10919055. DOI: 10.1186/s12916-024-03315-0.


TG: A Mediator of the Relationship of Serum Uric Acid to Creatinine Ratio and Nonalcoholic Fatty Liver Disease in Non-Obese Patients with Type 2 Diabetes.

Wang Q, Liu K, Zhang T, Wang T, Li H, Wang C Diabetes Metab Syndr Obes. 2024; 17:913-923.

PMID: 38435633 PMC: 10908273. DOI: 10.2147/DMSO.S451852.


Association Between Different Metabolic Markers and Metabolic Syndrome in an Outpatient Hyperuricemia Population: A Cross-Sectional Study.

Li X, Huang B, Liu Y, Wang M, Wang Y, Feng K Diabetes Metab Syndr Obes. 2023; 16:3967-3978.

PMID: 38077480 PMC: 10706058. DOI: 10.2147/DMSO.S443472.


References
1.
Ekstedt M, Hagstrom H, Nasr P, Fredrikson M, Stal P, Kechagias S . Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology. 2014; 61(5):1547-54. DOI: 10.1002/hep.27368. View

2.
Akhtar D, Iqbal U, Vazquez-Montesino L, Dennis B, Ahmed A . Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease. J Clin Transl Hepatol. 2020; 7(4):362-370. PMC: 6943204. DOI: 10.14218/JCTH.2019.00028. View

3.
Polonsky K, Rubenstein A . C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations. Diabetes. 1984; 33(5):486-94. DOI: 10.2337/diab.33.5.486. View

4.
Stojsavljevic S, Gomercic Palcic M, Virovic Jukic L, Smircic Duvnjak L, Duvnjak M . Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol. 2015; 20(48):18070-91. PMC: 4277948. DOI: 10.3748/wjg.v20.i48.18070. View

5.
Tucker B, Li H, Long X, Rye K, Ong K . Fibroblast growth factor 21 in non-alcoholic fatty liver disease. Metabolism. 2019; 101:153994. DOI: 10.1016/j.metabol.2019.153994. View